UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Highly sensitive scent-detection of COVID-19 patients in vivo by trained dogs

PloS one, 2021-09, Vol.16 (9), p.e0257474-e0257474

2021

Volltextzugriff (PDF)

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

PloS one, 2019-02, Vol.14 (2), p.e0211096-e0211096

2019

Volltextzugriff (PDF)

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone

PloS one, 2020-12, Vol.15 (12), p.e0243365

2020

Volltextzugriff (PDF)

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3271-3279

2010

Volltextzugriff (PDF)

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam

PloS one, 2016-05, Vol.11 (5), p.e0155806-e0155806

2016

Volltextzugriff (PDF)

Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2012, Vol.56 (1), p.243-247

2012

Volltextzugriff (PDF)

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

BMC infectious diseases, 2010-06, Vol.10 (1), p.153-153, Article 153

2010

Volltextzugriff (PDF)

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis

PloS one, 2015-11, Vol.10 (11), p.e0141872-e0141872

2015

Volltextzugriff (PDF)

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

BMC infectious diseases, 2006-03, Vol.6 (1), p.55-55, Article 55

2006

Volltextzugriff (PDF)

Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model

PloS one, 2010-05, Vol.5 (5), p.e10744

2010

Volltextzugriff (PDF)

Antifungal pharmacodynamics: Latin America's perspective

The Brazilian journal of infectious diseases, 2017-01, Vol.21 (1), p.79-87

2017

Volltextzugriff (PDF)

Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study

BMC infectious diseases, 2002-05, Vol.2 (1), p.8-8, Article 8

2002

Volltextzugriff (PDF)

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient

PloS one, 2019-02, Vol.14 (2), p.e0211096

2019

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Index Linked to In Vivo Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis

Antimicrobial agents and chemotherapy, 2023-02, Vol.67 (2), p.e0096622

2023

Volltextzugriff (PDF)

In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products

International journal of antimicrobial agents, 2017-02, Vol.49 (2), p.189-197

2017

Volltextzugriff (PDF)

Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.53-58

2015

Volltextzugriff (PDF)

Staphylococcus aureus resistente a vancomicina

Biomédica, 2005, Vol.25 (4), p.575-587

2005

Volltextzugriff (PDF)

Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae

BMC microbiology, 2005-06, Vol.5 (1), p.34-34, Article 34

2005

Volltextzugriff (PDF)

Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam

International journal of antimicrobial agents, 2015-02, Vol.45 (2), p.161-167

2015

Volltextzugriff (PDF)

Staphylococcus aureus resistente a vancomicina

Biomédica, 2005-12, Vol.25 (4), p.575-87

2005

Volltextzugriff (PDF)

Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model

BMC research notes, 2015-10, Vol.8 (1), p.546-546, Article 546

2015

Volltextzugriff (PDF)

OBTENCIÓN DE UN MODELO MÚRIDO DE DIABETES INDUCIDA POR ESTREPTOZOTOCINA ÚTIL EN LA EVALUACIÓN FARMACODINÁMICA DE LA INSULINA REGULAR

Vitae (Medellín), 2017, p.11-18

2017

Volltextzugriff (PDF)

A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice

Journal of biomedical science, 2015-03, Vol.22 (1), p.24-24, Article 24

2015

Volltextzugriff (PDF)

Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia

The Journal of infection, 2009-10, Vol.59 (4), p.277-280

2009

Volltextzugriff (PDF)

Obtención de un modelo múrido de diabetes inducida por estreptozotocina útil en la evaluación farmacodinámica de la insulina regular

Vitae (Medellín), 2017-01, Vol.24 (2), p.11

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Animals
(17)
Life Sciences & Biomedicine
(17)
Mice
(17)
Humans
(14)
Infectious Diseases
(14)
Microbial Sensitivity Tests
(13)
Disease Models, Animal
(12)
Anti-Bacterial Agents - Therapeutic Use
(11)
Staphylococcus Aureus
(9)
Staphylococcus Aureus - Drug Effects
(9)
Therapeutic Equivalency
(9)
Generic Drugs
(8)
Microbiology
(8)
Anti-Bacterial Agents - Pharmacology
(7)
Antibiotics
(7)
Drugs, Generic - Pharmacokinetics
(7)
Female
(7)
Neutropenia
(7)
Pharmacodynamics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Highly sensitive scent-detection of COVID-19 patients in vivo by trained dogs

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam

Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model

Antifungal pharmacodynamics: Latin America's perspective

Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient

Pharmacokinetic/Pharmacodynamic Index Linked to In Vivo Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis

In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products

Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin

Staphylococcus aureus resistente a vancomicina

Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae

Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam

Staphylococcus aureus resistente a vancomicina

Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model

OBTENCIÓN DE UN MODELO MÚRIDO DE DIABETES INDUCIDA POR ESTREPTOZOTOCINA ÚTIL EN LA EVALUACIÓN FARMACODINÁMICA DE LA INSULINA REGULAR

A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice

Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia

Obtención de un modelo múrido de diabetes inducida por estreptozotocina útil en la evaluación farmacodinámica de la insulina regular

Suchergebnisse filtern